| abstract |
The present disclosure includes, for example, malaria, barbes fever, toxoplasmosis, diarrheal disease, respiratory disease, sexually transmitted bacterial infections, and some bioterrorist bacteria, including, for example, plague, tularemia and post-inhalation anthrax. Novel salts and polymorphs of cetromycin are disclosed for the treatment of diseases caused by infection by bacteria and certain protozoa, including Also disclosed herein are novel salts and polymorphs of setromycin for the treatment of inflammatory diseases, including, for example, pelvic inflammatory disease, and peptic ulcer disease. |